发明名称 Izolowana@cząsteczka@kwasu@nukleinowego@kodująca@ligand@TIE@wektor@zawierający@izolowaną@cząsteczkę@kwasu@nukleinowego@izolowany@i@oczyszczony@ligand@TIE@układ@gospodarz@wektor@sposób@wytwarzania@izolowanego@i@oczyszczonego@ligandu@TIE@przeciwciało@ciało@ligandu@koniugat@kompozycja@farmaceutyczna@zastosowanie@przeciwciała@zastosowanie@izolowanego@i@oczyszczonego@ligandu@sposób@in@vitro@podtrzymywania@w@hodowli@ekspresji@receptora@TIE@sposób@identyfikacji@antagonisty@receptora@TIE@ciało@receptora@izolowana@cząsteczka@k
摘要 The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptor body which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth or differentiation of a cell expressing the TIE-2 receptor, a method of blocking the growth or differentiation of a cell expressing the TIE-2 receptor and a method of attenuating or preventing tumor growth in a human.
申请公布号 PL184642(B1) 申请公布日期 2002.11.29
申请号 PL19950319586 申请日期 1995.10.06
申请人 发明人
分类号 G01N33/50;A61K38/00;A61K38/17;A61K39/395;A61K47/48;A61K48/00;A61K51/00;A61P9/10;A61P29/00;A61P31/04;A61P35/00;C07H21/04;C07K;C07K14/47;C07K14/515;C07K14/705;C07K16/28;C07K19/00;C12N;C12N5/06;C12N5/10;C12N15/00;C12N15/02;C12N15/09;C12N15/12;C12N15/19;C12N15/62;C12N15/63;C12P21/02;C12P21/08;C12R1/91;G01N33/53 主分类号 G01N33/50
代理机构 代理人
主权项
地址